Wide variability in drug use in out-of-hospital cardiac arrest: a report from the resuscitation outcomes consortium.
Resuscitation · 2012-07-30 · Registry study
Abstract
BACKGROUND: Despite the publication and dissemination of the Advanced Cardiac Life Support guidelines, variability in the use of drugs during resuscitation from out-of-hospital cardiac arrest may exist between different Emergency Medical Services throughout North America. The purpose of this study was to characterize the use of such drugs and evaluate their relationship to cardiac arrest outcomes. METHODS AND RESULTS: The Resuscitation Outcomes Consortium Registry-Cardiac Arrest collects out-of-hospital cardiac arrest data from 264 Emergency Medical Services agencies in 11 geographical locations in the U.S. and Canada. Multivariable logistic regression was used to assess the association between drug use, characteristics of the cardiac arrest and a pulse at emergency department arrival and survival to discharge. A total of 16,221 out-of-hospital cardiac arrests were attended by 74 Emergency Medical Services agencies. There was a considerable variability in the administration of amiodarone and lidocaine for the treatment of shock resistant ventricular tachycardia/ventricular fibrillation. For non-shockable rhythms, atropine use ranged from 29 to 95% and sodium bicarbonate use ranged from 0.2 to 73% across agencies in the 89% of agencies that used the drug. Epinephrine use ranged from 57 to 98% within agencies. Neither lidocaine nor amiodarone was associated with a survival benefit while there was an inverse relationship between the administration of epinephrine, atropine and sodium bicarbonate and survival to hospital discharge. CONCLUSIONS: There is considerable variability among Emergency Medical Services agencies in their use of pharmacological therapy for out-of-hospital cardiac arrests which may be resolved by performing large randomized trials examining effects on survival.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Adrenaline · Amiodarone · Anaesthetics · Atropine · Cardiovascular drugs · Lidocaine · Mortality & survival · Other drugs · Sodium bicarbonate
Related articles
- Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care. (Can J Cardiol, 2024)
- Drug use during adult advanced cardiac life support: An overview of reviews. (Resusc Plus, 2021)
- Antiarrhythmia drugs for cardiac arrest: a systemic review and meta-analysis. (Crit Care, 2013)
- Evaluation of out-of-hospital cardiopulmonary resuscitation with resuscitative drugs: a prospective comparative study in Japan. (Resuscitation, 2005)
- Resuscitation characteristics and outcomes in suspected drug overdose-related out-of-hospital cardiac arrest. (Resuscitation, 2014)
- Out-of-hospital pediatric cardiorespiratory arrest in Galicia: impact of the 2005 resuscitation guidelines. (Pediatr Emerg Care, 2011)